Sinotherapeutics Inc. A Cash Flow Quality Index
Sinotherapeutics Inc. A cash flow quality index. Sinotherapeutics Inc. A (688247) has a Cash Flow Quality Index of 2.01x as of December 2025. Operating cash flow of CN¥95.33 Million exceeds net income of CN¥47.48 Million, indicating high earnings quality where cash backs reported profits. See how financially flexible is Sinotherapeutics Inc. A to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sinotherapeutics Inc. A (2020–2025)
Cash flow quality index of Sinotherapeutics Inc. A from 2020 to 2025. Historical Cash Flow Quality Index for Sinotherapeutics Inc. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 688247 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Sinotherapeutics Inc. A Cash Flow Quality Index by Year (2020–2025)
Sinotherapeutics Inc. A cash flow quality index by year from 2020 to 2025. Year-by-year earnings quality comparison for Sinotherapeutics Inc. A. For the full cash flow conversion analysis, see how efficiently does Sinotherapeutics Inc. A generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.01x | CN¥95.33 Million | CN¥47.48 Million | ▲ +96.9% |
| 2024 | 1.02x | CN¥130.23 Million | CN¥127.70 Million | ▲ +380.7% |
| 2023 | 0.21x | CN¥12.96 Million | CN¥61.07 Million | ▼ -73.1% |
| 2022 | 0.79x | CN¥73.18 Million | CN¥92.94 Million | ▼ -27.1% |
| 2021 | 1.08x | CN¥145.77 Million | CN¥134.92 Million | ▼ -40.0% |
| 2020 | 1.80x | CN¥210.04 Million | CN¥116.54 Million | — |